Stay updated with breaking news from Leland Gershell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Call End: Veru Inc. (NASDAQ:NASDAQ:VERU) Q2 2022 Earnings Conference Call May 12, 2022 8:00 AM ET Company Participants Samuel Fisch - Executive Director, Investor Relations and Corporate...
In this article, we discuss 10 most anticipated quarterly earnings releases to watch.
UroGen Pharma Ltd. (NASDAQ:NASDAQ:URGN) Q1 2022 Earnings Conference Call May 10, 2022, 10:00 AM ET Company Participants Vincent Perrone - Senior Director of IR Liz Barrett - President and...
Veru Inc (VERU) stock is up 1.83% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.
Wall Street is growing more bullish on the biotech's prospects.